检索结果-南通市图书馆

molecular targeting agents associated with transarterial chemoembolization or radiofrequency ablation in hepatocarcinoma treatment

引用

World Journal of Gastroenterology 2014年第2期20卷 486-497页

作者： Girolamo Ranieri Ilaria Marech Vito Lorusso Veronica Goffredo Angelo Paradiso Domenico Ribatti Cosmo Damiano Gadaleta Interventional Radiology Unit with Integrated Section of Translational Medical Oncology National Cancer Research CentreCancer Institute "Giovanni Paolo Ⅱ"70124 BariItaly Medical Oncology Unit National Cancer Research CentreCancer Institute "Giovanni Paolo Ⅱ"70124 BariItaly Medical Oncology with Experimental Unit National Cancer Research CentreCancer Institute "Giovanni Paolo Ⅱ"70124 BariItaly Department of Basic Medical Sciences Neurosciences and Sensory OrgansSection of Human Anatomy and HistologyUniversity of Bari70124 BariItaly

Hepatocellular carcinoma(HCC)is the fifth most common cause of cancer in the *** to Barcelona Clinic Liver Cancer modified criteria,patients with early stage disease are candidate to radiofrequency ablation(RFA),while patients with intermediate stage HCC are usually treated by transarterial chemoembolization(TACE).TACE and RFA induce a transient devascularisation effect followed by strong neoangiogenic *** fact,after these procedures,it has been demonstrated an up-regulation of pro-angiogenic and growth factors such as vascular endothelial growth factor-A,which might contribute to accelerated progression in patients with incomplete *** studies have demonstrated that MAP-kinase and AKT pathways,in addition to neo-angiogenesis,have an important role in the development of *** advanced HCC,anti-angiogenic therapy and tyrosine kinases inhibitors showed potential clinical ***,a number of clinical studies are ongoing testing these agents in combination with TACE or *** this paper,we have reviewed the most recent preclinical and clinical results of such trials.

关键词： Hepatocellular carcinoma molecular targeting agents Angiogenesis Chemoembolization therapeutic Radiofrequency treatment Sorafenib

来源：

维普期刊数据库评论

在线全文

维普期刊数据库

学校读者我要写书评

暂无评论

Quantitative examination of the inhibitory activation of molecular targeting agents in hepatocellular carcinoma patient-derived cell invasion via a novel in vivo tumor model

引用

Animal Models and Experimental Medicine 2019年第4期2卷 259-268页

作者： Huiwei Sun Fan Feng Hui Xie Xiaojuan Li Qiyu Jiang Yantao Chai Zhijie Wang Ruichuang Yang Ruisheng Li Jun Hou Research Center for Clinical and Translational Medicine The Fifth Medical CenterGeneral Hospital of Chinese PLABeijingChina Center for Clinical Laboratory The Fifth Medical CenterGeneral Hospital of Chinese PLABeijingChina Department of Interventional Therapy The Fifth Medical CenterGeneral Hospital of Chinese PLABeijingChina Medical School of Chinese PLA BeijingChina

Background: The outcomes for patients with advanced hepatocellular carcinoma(HCC) receiving sorafenib are far from satisfactory because of treatment resistance to sorafenib. However, the exact mechanism of resistance to sorafenib remains unclear and it is valuable to establish a novel mouse model to quantitatively analyze the inhibition rates of sorafenib on the invasive growth of HCC cells in the ***: HCC tissue microblocks derived from patients were cultured and mixed with hydrogel drops. Then, hydrogel drops containing microblocks of HCC tissue were attached onto the surface of the livers of nude mice to form lesions or nodules of HCC. The mice received molecular targeting agents through oral administration. Livers with tumor nodules were harvested for H&E staining(hematoxylin-eosin staining) analysis and H&E staining images were quantitatively analyzed using image J software. The invasive growth of HCC cells into the liver was calculated using the depth of the lesions compared with the total thickness of the ***: Microblocks containing cells derived from HCC patients can form lesions in the liver of nude mice. Oral administration of molecular targeting agents inhibited the invasive growth of HCC cells in the liver of nude ***: The model established in this study involves the invasive growth of HCC cells in the liver of nude mice, and the model allows for the quantitative analysis of the inhibitory effect of molecular targeting agents on the invasion of HCC cells in vivo.

关键词： hepatocellular carcinoma in vivo invasion molecular targeting agents patient‐derived cells

来源：

维普期刊数据库

同方期刊数据库评论

在线全文

学校读者我要写书评

暂无评论

欢迎您,

建议与咨询留下您的常用邮箱和电话号码，以便我们向您反馈解决方案和替代方法

时间限定

文献类型

馆藏选择

核心期刊

语言

文献类型

帮助

文字说明：

检索规则说明：

检索范例：

分类表

所选分类

限定检索结果

文献类型

馆藏范围

日期分布

学科分类号

主题

机构

作者

语言

在线全文

在线全文

请选择保存的检索档案：

请选择收藏分类：

通借通还

欢迎您,

建议与咨询 留下您的常用邮箱和电话号码，以便我们向您反馈解决方案和替代方法

时间限定

文献类型

馆藏选择

核心期刊

语言

文献类型

帮助

文字说明：

检索规则说明：

检索范例：

分类表

所选分类

限定检索结果

文献类型

馆藏范围

日期分布

学科分类号

主题

机构

作者

语言

在线全文

在线全文

请选择保存的检索档案： 新增检索档案 确定 取消

请选择收藏分类： 新增自定义分类 确定 取消

通借通还

建议与咨询留下您的常用邮箱和电话号码，以便我们向您反馈解决方案和替代方法

请选择保存的检索档案：

请选择收藏分类：